GMP-approved injectable drug delivery manufacturer serving oncology and urology
GP-Pharm manufactures injectable pharmaceuticals using proprietary microsphere and liposome delivery systems, with GMP-certified facilities near Barcelona. The tech stack—SCADA, PLCs, OPC UA, HPLC, and CAD tools—reflects a manufacturing-operations focus typical of regulated pharma, while active projects on aseptic-filling validation, SCADA implementation, and process digitalization signal ongoing infrastructure modernization. Leadership gaps in sales and marketing (2 roles filled, multiple director hires underway) suggest scaling distribution is a priority alongside operational compliance.
Notable leadership hires: Sales Director, National Sales Director
GP-Pharm is a Spanish biopharmaceutical company specializing in research, development, manufacturing, and commercialization of injectable products. The company focuses on three therapeutic areas—urology, oncology, and women's health—using proprietary drug-delivery platforms based on microspheres and liposomes. Founded in 2000, GP-Pharm operates GMP-approved manufacturing facilities and serves both direct pharma customers and contract-manufacturing partners. The organization spans 51–200 employees across quality, engineering, manufacturing, and commercial functions, with headquarters in l'Hospitalet de Llobregat, Barcelona.
GP-Pharm operates SCADA systems, PLCs, OPC UA, Modbus TCP/IP, HPLC, and CAD for process control and product development. The stack emphasizes industrial automation and analytical chemistry tools common in regulated pharmaceutical manufacturing.
GP-Pharm's manufacturing facilities are located in Sant Quintí de Mediona, near Barcelona, Spain. The facilities are GMP-approved and certified for injectable-product production.
Other companies in the same industry, closest in size